00:20:46 EDT Thu 28 May 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:ICO from 2019-05-29 to 2020-05-28 - 29 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2020-05-19 12:51C:ICOiCo Therapeutics Inc0.05News ReleaseiCo Therapeutics spends $917,475 on R&D in 2019
2020-05-15 21:12C:ICOiCo Therapeutics Inc0.05SEDAR Annual Information FormSEDAR Annual Information Form
2020-05-15 19:56C:ICOiCo Therapeutics Inc0.05SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2020-05-15 19:56C:ICOiCo Therapeutics Inc0.05SEDAR MD & ASEDAR MD & A
2020-04-27 20:30C:ICOiCo Therapeutics Inc0.05News ReleaseiCo Therapeutics postpones filing of 2019 financials
2020-04-15 09:02C:ICOiCo Therapeutics Inc0.04News ReleaseiCo Therapeutics appoints Wasan as director, research
2020-03-09 11:25C:ICOiCo Therapeutics Inc0.05News ReleaseiCo appoints Koppy as president, Jarosz as CEO
2020-02-25 09:43C:ICOiCo Therapeutics Inc0.06News ReleaseiCo completes phase 1b oral amphotericin B study
2020-02-10 08:28C:ICOiCo Therapeutics Inc0.07News ReleaseiCo completes dosing of oral amphotericin B study
2020-01-10 20:37C:ICOiCo Therapeutics Inc0.08News ReleaseiCo Therapeutics grants options to buy 2M shares
2019-12-24 08:10C:ICOiCo Therapeutics Inc0.06News ReleaseiCo completes sublicence transfer of iCo-008
2019-12-11 21:09C:ICOiCo Therapeutics Inc0.06News ReleaseiCO Therapeutics hires Ora for iCo-008 research
2019-12-09 08:43C:ICOiCo Therapeutics Inc0.06News ReleaseiCo completes dosing of first cull cohort in study
2019-12-02 10:16C:ICOiCo Therapeutics Inc0.07News ReleaseiCo Therapeutics spends $84,253 on R&D in Q3 2019
2019-11-29 16:16C:ICOiCo Therapeutics Inc0.06SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-11-29 16:16C:ICOiCo Therapeutics Inc0.06SEDAR MD & ASEDAR MD & A
2019-11-25 08:26C:ICOiCo Therapeutics Inc0.07News ReleaseiCo Therapeutics has a new partner for iCo-008
2019-10-28 17:43C:ICOiCo Therapeutics Inc0.075News ReleaseiCo to start dosing in oral amphotericin study
2019-10-22 09:16C:ICOiCo Therapeutics Inc0.085News ReleaseiCo receives court OK for sale order of assets
2019-09-03 17:31C:ICOiCo Therapeutics Inc0.09Private PlacementiCo Therapeutics 41.2-million-share private placement
2019-08-28 19:41C:ICOiCo Therapeutics Inc0.085SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-08-28 19:28C:ICOiCo Therapeutics Inc0.085SEDAR MD & ASEDAR MD & A
2019-08-28 17:13C:ICOiCo Therapeutics Inc0.085News ReleaseiCo Therapeutics spends $156,333 on R&D in Q2
2019-08-19 09:39C:ICOiCo Therapeutics Inc0.08News ReleaseiCo Therapeutics closes $2.06-million private placement
2019-08-06 03:03C:ICOiCo Therapeutics Inc0.085News ReleaseiCo amending Amphotericin B clinical application
2019-06-28 08:30C:ICOiCo Therapeutics Inc0.065News ReleaseiCo Therapeutics shareholders appoint four to board
2019-05-30 16:57C:ICOiCo Therapeutics Inc0.065SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-05-30 16:57C:ICOiCo Therapeutics Inc0.065SEDAR MD & ASEDAR MD & A
2019-05-30 16:47C:ICOiCo Therapeutics Inc0.065News ReleaseiCo Therapeutics spends $85,095 on R&D in Q1 2019